However, neither the actual mechanisms by which chemotherapy triggered the IFN/STAT1 pathway in these breast cancer PDXs nor the actual contribution of the ISG fingerprint to the tumor response were elucidated. This evidence concerns the gene STAT1 and breast carcinoma.